Stay updated on XmAb24306+Cevostamab Safety/PK/Activity in Multiple Myeloma Clinical Trial

Sign up to get notified when there's something new on the XmAb24306+Cevostamab Safety/PK/Activity in Multiple Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the XmAb24306+Cevostamab Safety/PK/Activity in Multiple Myeloma Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    A site-wide NIH notice announces that federal agencies are transitioning from the term “Artificial Intelligence” to “Super Intelligence.”
    Difference
    0.5%
    Check dated 2026-10-25T15:44:06.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.1 to v3.7.2.
    Difference
    0.1%
    Check dated 2026-10-18T20:51:40.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision indicator changed from v3.7.0 to v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-11T20:52:24.000Z thumbnail image
  4. Check
    39 days ago
    Change Detected
    Summary
    The page’s version label changes from v3.6.6 to v3.7.0, signaling a software update to the history view of the study record.
    Difference
    0.1%
    Check dated 2026-09-20T22:38:13.000Z thumbnail image
  5. Check
    60 days ago
    Change Detected
    Summary
    The study record history shows the latest revision updated from v3.6.5 to v3.6.6, reflecting a metadata update to the page's version history.
    Difference
    0.1%
    Check dated 2026-08-30T21:47:21.000Z thumbnail image
  6. Check
    75 days ago
    Change Detected
    Summary
    An older history entry dated 2026-05-14 was removed and a new Study Status entry dated 2026-08-11 was added, marking an update to the trial's recruitment status in the record.
    Difference
    0.3%
    Check dated 2026-08-16T14:58:16.000Z thumbnail image

Stay in the know with updates to XmAb24306+Cevostamab Safety/PK/Activity in Multiple Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the XmAb24306+Cevostamab Safety/PK/Activity in Multiple Myeloma Clinical Trial page.